Which has the lower trailing P/E, HUM or LLY?

HUM has the lower trailing P/E: HUM trades at 40.76 and LLY at 42.54. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, HUM or LLY?

Over the past five years, LLY grew revenue faster — HUM at a 11.71% CAGR versus LLY at 23.17%.

Does HUM or LLY pay a bigger dividend?

HUM yields 0.70% and LLY yields 0.54% based on trailing dividends and the latest price.

Is HUM or LLY more profitable?

LLY runs the higher net margin — HUM at 0.82% versus LLY at 34.98%.

How have HUM and LLY total returns compared?

Over the past 10 years, HUM delivered 9.18% and LLY delivered 32.66% annualized total return. Past performance doesn't predict future results.

Humana Inc. (HUM) vs Eli Lilly and Company (LLY)

A side-by-side comparison of Humana Inc. and Eli Lilly and Company across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of July 28, 2026. Differences are shown without an overall score or investment verdict.

HUM

Humana Inc.

$46.67B

$388.71HealthcareDelayed quote: Jul 28, 2026, 4:01 PM EDT

LLY

Eli Lilly and Company

$1.15T

$1,222.61HealthcareDelayed quote: Jul 28, 2026, 4:00 PM EDT

Total return — HUM vs LLY

growth of $100 · dividends reinvested · last 30y

HUM +2547.6%LLY +8631.2%LLY compounded faster

HUM LLY

HUM vs LLY: by the numbers

•LLY is the larger company ($1.15T vs $46.67B market cap).
•HUM trades at the lower trailing earnings multiple (40.76 vs 42.54 P/E), one valuation lens rather than an overall verdict.
•LLY converts more revenue to profit (34.98% vs 0.82% net margin).
•LLY grew revenue faster over the past five years (23.17% vs 11.71% CAGR).
•HUM pays the higher dividend yield (0.70% vs 0.54%).

Metrics side by side

Valuation

Metric	HUM	LLY
P/E ratio	40.76	42.54
Forward P/E	42.42	34.10
P/S ratio	0.34	14.85
P/B ratio	2.48	34.39
PEG ratio	N/A	0.49
EV / EBITDA	25.16	31.98
FCF yield	2.77%	1.27%

Profitability

Metric	HUM	LLY
Gross margin	14.01%	83.51%
Operating margin	1.01%	45.87%
Net margin	0.82%	34.98%
ROE	6.08%	81.01%
ROIC	3.12%	30.20%

Dividends

Metric	HUM	LLY
Dividend yield	0.70%	0.54%
Payout ratio	26.90%	28.09%

Growth (annualized)

Metric	HUM	LLY
Revenue CAGR (5Y)	11.71%	23.17%
EPS CAGR (5Y)	-17.27%	28.88%
FCF CAGR (5Y)	-17.19%	19.54%
Total return CAGR (5Y)	-1.91%	38.81%

Frequently asked

Which has the lower trailing P/E, HUM or LLY?: HUM has the lower trailing P/E: HUM trades at 40.76 and LLY at 42.54. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, HUM or LLY?: Over the past five years, LLY grew revenue faster — HUM at a 11.71% CAGR versus LLY at 23.17%.
Does HUM or LLY pay a bigger dividend?: HUM yields 0.70% and LLY yields 0.54% based on trailing dividends and the latest price.
Is HUM or LLY more profitable?: LLY runs the higher net margin — HUM at 0.82% versus LLY at 34.98%.
How have HUM and LLY total returns compared?: Over the past 10 years, HUM delivered 9.18% and LLY delivered 32.66% annualized total return. Past performance doesn't predict future results.

Go deeper

Full HUM analysis Full LLY analysis Interactive comparison tool

Dig into the metrics

Humana P/E ratio Eli Lilly and P/E ratio Humana dividend yield Eli Lilly and dividend yield Humana ROE Eli Lilly and ROE Humana operating margin Eli Lilly and operating margin Humana revenue growth Eli Lilly and revenue growth Humana free cash flow Eli Lilly and free cash flow

Humana & Eli Lilly and appear in these rankings

Fastest Revenue Growth Stocks Highest ROE Stocks Highest ROIC Stocks Highest Operating Margin Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified July 28, 2026.